JERUSALEM--(BUSINESS WIRE)-- BioLineRx (NAS: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that following promising pre-clinical data, EDP-14, for the treatment of ...

View BioLineRX Ltd. Sponsored ADR BLRX stock quote prices, financial information, real-time forecasts, and company news from CNN.

(RTTNews) - BioLineRx Ltd. (BLRX) said that phase 1/2a Study of investigational anti-tumor vaccine AGI-134 in unresectable metastatic solid tumors met its primary endpoint of safety and tolerability.

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage ...

TEL AVIV, Israel, May 20, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, ...

BioLineRx partnered with Hemispherian to conduct a trial testing GLIX1 in patients with Glioblastoma. ・Early preclinical data showed strong anti-tumor activity, good brain penetration, and a favorable ...

TEL AVIV, Israel, May 30, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare disease, today ...

Bioline RX Ltd Sponsored ADR ( (BLRX)) has released its Q3 earnings. Here is a breakdown of the information Bioline RX Ltd Sponsored ADR presented to its investors. Unlock your investing potential ...

TEL AVIV, Israel, March 16, 2026 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and ...

BioLineRx Ltd’s (NASDAQ:BLRX) poster, which includes new data from the single-arm pilot phase of the investigator-initiated, randomized CheMo4METPANC Phase 2 combination trial, will be presented at ...